Sinovac nabs Chinese vaccine tenders for hep A, influenza

It's a good week to be Sinovac, which has won a pair of vaccine tenders in China. On Monday, the company announced that the Beijing Health Bureau had declared it the sole supplier of inactivated hepatitis A vaccine to its Expanded Program of Immunization--a tender worth about 16 million RMB ($2.6 million). And on Wednesday, Beijing's Centers for Disease Control and Prevention selected it as a supplier of seasonal flu vaccines. Release | Release

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.